This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Shane Michael Walls: Innovator in FGFR3 Inhibitor Compounds
Introduction
Shane Michael Walls is a notable inventor based in Lafayette, CO (US). He has made significant contributions to the field of medical research, particularly in the development of FGFR3 inhibitor compounds. With a total of 4 patents, his work focuses on addressing critical health issues.
Latest Patents
Shane's latest patents include innovative compounds designed for the treatment of systemic sclerosis, fibrosis, achondroplasia, thanatophoric dysplasia, severe achondroplasia with developmental delay, and acanthosis nigricans. These compounds aim to provide therapeutic solutions for various conditions, including cancer.
Career Highlights
Shane is currently employed at Eli Lilly and Company, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective treatments in the medical field.
Collaborations
Shane collaborates with talented individuals such as Adedoyin David Abraham and Desta Doro Bume, who contribute to his innovative projects and research initiatives.
Conclusion
Shane Michael Walls exemplifies the spirit of innovation in the medical research sector. His contributions through patents and collaborations are paving the way for advancements in treatment options for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile